Amneal Pharmaceuticals LLC is a leading pharmaceutical company based in Hauppauge, NY. They challenge convention to make healthy living possible by creating essential medicines, including a broad portfolio of approximately 270 generic and specialty pharmaceuticals. With a commitment to delivering value, Amneal invests significantly in new product development and reduces barriers for patients accessing the medicines they need most, including those in the oncology field. Their culture is driven by actions that inspire them to rise, lead, and succeed for patients and their families.
As of November 7, 2023, Amneal has three reportable business segments: Generics, which includes retail, injectables, biosimilars, and international revenue; Specialty; and AvKARE, which includes distribution, government label, and institutional revenue. With a focus on patient assistance programs, product donations, compliance ethics, and more, Amneal is dedicated to responsibly helping patients live better lives. They have expanded their portfolios to institutions, biosimilars, and select international markets, diversifying beyond generics to deliver value in complex retail generics, injectables, specialty, and international markets.
Generated from the website